Cystic  	Cystic  	 NNP	B-NP
Fibrosis  	Fibrosis  	 NNP	I-NP
Foundation  	Foundation  	 NNP	I-NP
practice  	practice  	 NN	I-NP
guidelines  	guidelines  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
infants  	infants  	 NNS	O
with  	with  	 IN	O
cystic  	cystic  	 FW	B-NP
fibrosis  	fibrosis  	 FW	I-NP
transmembrane  	transmembrane  	 FW	I-NP
conductance  	conductance  	 FW	I-NP
regulator-related  	regulator-related  	 FW	O
metabolic  	metabolic  	 FW	B-NP
syndrome  	syndrome  	 NN	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
two  	two  	 CD	O
years  	years  	 NNS	O
of  	of  	 IN	O
life  	life  	 NN	O
and  	and  	 CC	O
beyond  	beyond  	 IN	O
Through  	Through  	 IN	O
early  	early  	 JJ	O
detection 	detection 	 NN	O
,  	,  	 ,	O
newborn  	newborn  	 JJ	B-NP
screening  	screening  	 NN	I-NP
( 	( 	 -LRB-	O
NBS 	NBS 	 NNP	B-NP
) 	) 	 -RRB-	O
( 	( 	 -LRB-	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
cystic  	cystic  	 JJ	B-NP
fibrosis  	fibrosis  	 NNS	I-NP
( 	( 	 -LRB-	O
CF 	CF 	 NNP	B-NP
)  	)  	 -RRB-	O
offers  	offers  	 VBZ	O
the  	the  	 DT	O
opportunity  	opportunity  	 NN	O
for  	for  	 IN	O
early  	early  	 JJ	O
intervention  	intervention  	 NN	B-NP
and  	and  	 CC	O
improved  	improved  	 JJ	O
outcomes 	outcomes 	 NNS	O
.  	.  	 .	O
NBS  	NBS  	 NNP	B-NP
programs  	programs  	 NNS	O
screen  	screen  	 NN	O
for  	for  	 IN	O
hypertrypsinogenemia 	hypertrypsinogenemia 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
most  	most  	 RBS	O
also  	also  	 RB	O
identify  	identify  	 VB	O
mutations  	mutations  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
CF  	CF  	 NNP	B-NP
transmembrane  	transmembrane  	 FW	I-NP
conductance  	conductance  	 FW	I-NP
regulator  	regulator  	 FW	I-NP
( 	( 	 -LRB-	O
CFTR 	CFTR 	 NNP	B-NP
)  	)  	 -RRB-	O
gene 	gene 	 NN	O
.  	.  	 .	O
Individuals  	Individuals  	 NNS	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
NBS  	NBS  	 NNP	B-NP
are  	are  	 VBP	O
diagnosed  	diagnosed  	 VBN	O
with  	with  	 IN	O
CF  	CF  	 NNP	B-NP
if  	if  	 IN	O
they  	they  	 PRP	O
have  	have  	 VBP	O
an  	an  	 DT	O
elevated  	elevated  	 JJ	O
sweat  	sweat  	 NN	B-NP
chloride  	chloride  	 NN	I-NP
level  	level  	 NN	I-NP
or  	or  	 CC	O
if  	if  	 IN	O
they  	they  	 PRP	O
have  	have  	 VBP	O
inherited  	inherited  	 VBN	O
2  	2  	 CD	O
disease-causing  	disease-causing  	 JJ	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
CFTR  	CFTR  	 NNP	B-NP
gene 	gene 	 NN	I-NP
.  	.  	 .	O
Mutations  	Mutations  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
CFTR  	CFTR  	 NNP	B-NP
gene  	gene  	 NN	I-NP
can  	can  	 MD	O
cause  	cause  	 VB	O
CF 	CF 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
all  	all  	 DT	O
CFTR  	CFTR  	 NNP	B-NP
mutations  	mutations  	 NNS	I-NP
are  	are  	 VBP	O
disease-causing 	disease-causing 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
term  	term  	 NN	B-NP
CFTR-related  	CFTR-related  	 JJ	I-NP
metabolic  	metabolic  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
( 	( 	 -LRB-	O
CRMS 	CRMS 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
proposed  	proposed  	 VBN	O
to  	to  	 TO	O
describe  	describe  	 VB	O
infants  	infants  	 NNS	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
hypertrypsinogenemia  	hypertrypsinogenemia  	 NN	B-NP
on  	on  	 IN	O
NBS  	NBS  	 NNP	B-NP
who  	who  	 WP	O
have  	have  	 VBP	O
sweat  	sweat  	 JJ	B-NP
chloride  	chloride  	 NN	I-NP
values  	values  	 VBZ	O
< 	< 	 SYM	O
60  	60  	 CD	O
mmol 	mmol 	 CD	B-NP
/ 	/ 	 CD	I-NP
L  	L  	 NNP	I-NP
and  	and  	 CC	O
up  	up  	 RB	O
to  	to  	 TO	O
2  	2  	 CD	O
CFTR  	CFTR  	 NN	B-NP
mutations 	mutations 	 NNS	I-NP
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
1  	1  	 CD	O
of  	of  	 IN	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
not  	not  	 RB	O
clearly  	clearly  	 RB	O
categorized  	categorized  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
CF-causing  	CF-causing  	 JJ	B-NP
mutation 	mutation 	 NN	I-NP
,  	,  	 ,	O
thus  	thus  	 RB	O
they  	they  	 PRP	O
do  	do  	 VBP	O
not  	not  	 RB	O
meet  	meet  	 VB	O
CF  	CF  	 NNP	B-NP
Foundation  	Foundation  	 NNP	I-NP
guidelines  	guidelines  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
CF 	CF 	 NNP	B-NP
.  	.  	 .	O
With  	With  	 IN	O
what  	what  	 WP	O
is  	is  	 VBZ	O
now  	now  	 RB	O
near-universal  	near-universal  	 JJ	B-NP
CF  	CF  	 NNP	I-NP
NBS  	NBS  	 NNP	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States 	States 	 NNPS	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
increasing  	increasing  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
infants  	infants  	 NNS	O
with  	with  	 IN	O
CRMS  	CRMS  	 NNP	B-NP
are  	are  	 VBP	O
being  	being  	 VBG	O
identified 	identified 	 VBN	O
.  	.  	 .	O
Given  	Given  	 VBN	O
our  	our  	 PRP$	O
inadequate  	inadequate  	 JJ	O
knowledge  	knowledge  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
natural  	natural  	 JJ	O
history  	history  	 NN	O
of  	of  	 IN	O
CRMS 	CRMS 	 NNP	B-NP
,  	,  	 ,	O
standards  	standards  	 NNS	O
for  	for  	 IN	O
diagnosis 	diagnosis 	 NN	O
,  	,  	 ,	O
monitoring 	monitoring 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
are  	are  	 VBP	O
absent 	absent 	 VBN	O
.  	.  	 .	O
This  	This  	 DT	O
document  	document  	 NN	O
aims  	aims  	 VBZ	O
to  	to  	 TO	O
help  	help  	 VB	O
guide  	guide  	 VB	O
the  	the  	 DT	O
monitoring  	monitoring  	 NN	O
and  	and  	 CC	O
care  	care  	 NN	O
of  	of  	 IN	O
individuals  	individuals  	 NNS	O
with  	with  	 IN	O
CRMS  	CRMS  	 NNP	B-NP
while  	while  	 IN	O
our  	our  	 PRP$	O
knowledge  	knowledge  	 NN	B-NP
base  	base  	 NN	I-NP
on  	on  	 IN	O
appropriate  	appropriate  	 JJ	O
management  	management  	 NN	O
evolves 	evolves 	 NN	O
.  	.  	 .	O
